Krystal Biotech, INC 8-K filings

NASDAQ

26 Feb 2024

KRYS

8-K: Krystal Biotech Reports Strong 2023 Results and Advances Pipeline

Krystal Biotech announced positive financial results for 2023, driven by the commercial launch of VYJUVEK, and provided updates on its clinical pipeline.